Contract Services Investment Update

Publication
Article
BioPharm InternationalBioPharm International-03-15-2018
Volume 2018 eBook
Issue 1
Pages: 33-35

A review of the latest investments in facilities, equipment, and acquisitions by biopharma contract service providers.

Biopharmaceutical contract service providers have advanced their capabilities and offerings to help their clients tackle industry challenges and accelerate innovations. The author explores some of the latest investments in facilities and equipment by contract service providers, as well as the mergers and acquisitions market.

Read this article in BioPharm International's Outsourcing Resources 2018 eBook.

View other articles in BioPharm International's Outsourcing Resources 2018 eBook.

Article Details

BioPharm International
eBook: Outsourcing Resources 2018
March 2018
Pages: 33–35

Citation

When referring to this article, please cite it as A. Lowry, “Contract Services Investment Update," BioPharm International Outsourcing Resources 2018 (March 2018).

Articles in this issue
Quality Oversight During Sterile Filling Operations
Quality Oversight During Sterile Filling Operations
Good Quality Agreements Support Compliance with CGMP
Good Quality Agreements Support Compliance with CGMP
Gaining Analytical Insight in the Development of Biologics
Gaining Analytical Insight in the Development of Biologics
BP0318eBook_033-035_Investment-Update-1.jpg
Contract Services Investment Update
Process Validation in Biologics Development
Process Validation in Biologics Development
Bigger is Better in Samsung's Approach to Biomanufacturing
Bigger is Better in Samsung's Approach to Biomanufacturing
Choosing an Analytical Partner in Early Drug Development
Choosing an Analytical Partner in Early Drug Development
Outsourcing: Does Focus Pay Off?
Outsourcing: Does Focus Pay Off?
Avoiding Complete Response Letters
Avoiding Complete Response Letters
Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
CDMO

5 CDMOs to Watch in 2025

Alicia Bigica
December 20th 2024
Article

Contract development and manufacturing organizations (CDMOs) are more critical than ever as the demand for advanced therapies continues to grow.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Scinai Immunotherapeutics Forms CDMO Subsidiary in US

Feliza Mirasol
December 18th 2024
Article

The company has formed Scinai Bioservices Inc., new US-based subsidiary operating out of Delaware that will serve biotech companies in early stage drug development.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

Feliza Mirasol
December 17th 2024
Article

In the latest of a series of acquisitions this year, AbbVie will acquire Nimble Therapeutics, which includes that company’s lead asset, an oral peptide for treating psoriasis.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

AbbVie Completes $1.4 Billion Acquisition of Aliada Therapeutics, Boosting Neuroscience Pipeline

Susan Haigney
December 17th 2024
Article

AbbVie has completed its $1.4 billion acquisition of Aliada Therapeutics, giving it access to Aliada’s disease-modifying therapy for Alzheimer’s disease.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Intertek and CrystecPharma Partner to Advance Formulation and Development of Dry Powder Inhaler Products

Feliza Mirasol
December 12th 2024
Article

The companies will develop a platform that can enable rapid development of DPI products.

© 2024 MJH Life Sciences

All rights reserved.